Tenax Therapeutics Inc. buy melinda
Start price
29.08.18
/
50%
€96.69
Target price
23.01.19
€111.85
Performance (%)
-77.61%
End price
23.01.19
€21.65
Summary
This prediction ended on 23.01.19 with a price of €21.65. Massive losses of -77.61% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tenax Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3.178% | 0.980% | 15.331% | 18.044% |
| iShares Nasdaq 100 | 2.972% | 0.925% | 39.831% | 50.841% |
| iShares Nikkei 225® | 0.545% | -4.556% | 17.661% | 3.434% |
| iShares S&P 500 | 2.367% | 0.833% | 30.000% | 44.095% |
Comments by melinda for this prediction
In the thread Tenax Therapeutics Inc. diskutieren
SecteurRecherche biotechnologique et médicale Agenda 08/11 Publication de résultats
Métier
Logo Tenax Therapeutics IncDiscovers, develops and commercializes novel therapeutic products
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market.
Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure.
The company was founded on May 26, 1967 and is headquartered in Morrisville, NC.
Nombre d'employés : 8 personnes
(Vom Mitglied beendet)
Stopped prediction by melinda for Tenax Therapeutics Inc.
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.64
18.10.22
18.10.22
€8.00
18.10.23
18.10.23
-44.51%
19.10.23
19.10.23
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.80
13.12.20
13.12.20
€24.00
13.12.21
13.12.21
15.73%
14.12.21
14.12.21
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€26.12
25.08.20
25.08.20
€40.00
04.11.21
04.11.21
-31.85%
13.12.20
13.12.20
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€328.33
03.02.17
03.02.17
€360.80
03.08.17
03.08.17
-51.69%
03.08.17
03.08.17
Tenax Therapeutics Inc.
Start price
Target price
Perf. (%)
€18,000
14.06.10
14.06.10
€32,000
15.12.10
15.12.10
-37.33%
15.12.10
15.12.10